The effect of Mexidol on cerebral mitochondriogenesis at a young age and during aging
This article is in "Library" section.
Author:
YU.I. KIROVA1, F.M. SHAKOVA1, E.L. GERMANOVA1, G.A. ROMANOVA1, T.A. VORONINA2
1 Institute of General Pathology and Pathophysiology, Moscow, Russia;
2 Zakusov Research Institute of Pharmacology, Moscow, Russia
The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients
This article is in "Library" section.
Author:
O.V. M.V. ZHURAVLEVA1,2, A.B. PROKOFIEV1,2, V.V. ARKHIPOV1, S.YU. SEREBROVA1,2, G.I. GORODETSKAY1,2, O.A. DEMIDOVA1
1 Research center for examination of medical devices, Moscow, Russia
2 Sechenov First Moscow state medical University (Sechenov University), Moscow, Russia
Mexidol® and Mexidol® FORTE 250 are reference (original) preparations
LLC “Scientific Production Company “PHARMASOFT” reports receipt of a letter (No. 20-3/545 of 13.04.2020) from the Department for State Regulation of the Circulation of Medicines of the Ministry of Health of the Russian Federation which confirms that the following drugs are reference (original) ones1: Mexidol® in the pharmaceutical form “film-coated tablets, 125 mg” (LSR-002063/07 of 09.08.2007) and "solution for intravenous and intramuscular administration, 50 mg/mm (P N002161/0l of 14.03.2008), as well as Mexidol® FORTE 250 in the pharmaceutical form “film-coated tablets, 250 mg” (LP-004831 of 26.04.2018) (owner or holder of the registration certificate - LLC “Scientific Production Company “PHARMASOFT”, Russia).
1 Letter from the Federal State Budgetary Institution “Scientific Centre for Expert Evaluation of Medicinal Products” of the Ministry of Health of Russia No. 7358 dated 07.04.2020.
Efficacy and safety of the drug Mexidol forte 250 as part of long-term sequential therapy in patients with carotid stroke
This article is in "Library" section.
Author:
I.A. STRELNIKOVA1, A.A. SVETKINA1,2, O.V. ANDROFAGINA1
1 Samara Regional Clinical Hospital named after V.D. Seredavina, Samara, Russia;
2 Samara State Medical University, Samara, Russia
Possibility of application Mexidol for the treatment of patients suffering from sensorineural hearing loss and cerebrovascular insufficiency
This article is in "Library" section.
Author:
N.L. KUNELSKAYA1, 2, YU.V. LEVINA1, 2, E.S. YANYUSHKINA1, D.S. OGORODNIKOV1, 2, E.V. LARIONOVA1
1 L.I. Sverzhevskiy Research Institute of Clinical Otorhinolaryngology, Moscow Health Department, Moscow, Russia, 117152;
2 Department of Otorhinolaryngology N.I.Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia,117997
The study of the efficacy and safety of Mexidol and Mexidol Forte in patients with chronic cerebral ischemia
This article is in "Library" section.
Author:
V.A. KUTASHOV, O. V. ULYANOVA
Voronezh State Medical University. N.N. Burdenko, Voronezh, Russia
Effect of mexidol on physical and mental performance under stressogenic conditions in experiment
This article is in "Library" section.
Author:
I.G. KAPITSA, E.A. IVANOVA, T.A. VORONINA
FSBI «Zakusov Institute of Pharmacology», Moscow
Improvement of the efficacy of treatment of hypertensive encephalohathy by using mexidol
This article is in "Library" section.
Author:
E.V. BOLOTOVA, N.YU. LUSHPAY, I.V. KOVRIGINA
Kuban State Medical University under the Health Care Ministry of the Russia, Krasnodar, Russia; Reserch Institute — Territorial Clinical
Hospital №1 med after Professor S.V. Ochapovski under the Health Ministry of the Russia, Krasnodar, Russia
Review of clinical guidelines for the treatment and prevention of ischemic stroke
This article is in "Library" section.
Author:
A.I. FEDIN, K.R. BADALYAN
Pirogov Russian National Research Medical University, Russian Ministry of Health, Moscow, Russia
Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain
This article is in "Library" section.
Author:
E.I. CHUKANOVA, A.S. CHUKANOVA
Pirogov Russian National Research Medical University, Moscow, Russia